Baxter medication error
"The Food and Drug Administration and Baxter International Inc. are warning health-care professionals about mix-ups of two heparin products that resulted in the deaths of three infants. The FDA posted a Feb. 6 letter from Baxter discussing the medication errors to its Web site late Wednesday. The three deaths occurred when a higher dose of Heparin Sodium Injection, at 10,000 units a milliliter, was inadvertently administered instead of a lower dose of HEP-LOCK U/P at 10 units a milliliter. Both products are in the same-size vial and use different shades of blue as the prominent background color on their labels."
Jennifer Corbett Dooren, Wall Street Journal 2/08/07 (Subscription Only)
http://online.wsj.com/article/SB117095222262102389.html?mod=todays_us_marketplace
Bookmark: 
